AusPAR: Flucelvax Quad

Australian Public Assessment Report (AusPAR)

AusPAR

AusPAR: Flucelvax Quad [PDF, 1.42 MB]

AusPAR: Flucelvax Quad [Word, 1.26 MB]

Attachment Product information for Flucelvax Quad [PDF, 454.67 KB]

Attachment Product information for Flucelvax Quad [Word, 481 KB]

Device/Product Name

Flucelvax Quad

Active ingredients

Influenza virus haemagglutinin

AusPAR Date

1 November 2023

Published

6 November 2023

Submission Number

PM-2022-01977-1-2

Submission Type

Extension of indication

Decision

Approved